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Abstract-The isolation of uronic acid-containing glycosaminoglycans from peripheral 
nerve and spinal cord of monkey was done by combining the cetyl pyridinium procedure 
and DEAE-Sephadex column chromatography. The constituent analyses of the isolated 
GAG-fractions indicated that hyaluronic acid, chondroitin-4-sulphate, chondroi tin-6- 
sulphate, heparan sulphate and a testicular hyaluronidase-resistant galactosamine-containing 
GAG were present in both tissues. Hyaluronic acid was the predominant GAG (63 per cent) 
in both tissues and its level was much higher than in brain. Chondroitin-4-sulphate 
constituted 16 per cent in both tissues. The levels of heparan sulphate and hyaluronidase- 
resistant galactosamine-containing GAG in these tissues were much lower than in brain. 
The results indicate that the patterns of GAGs in peripheral nerve and spinal cord of 
monkey are similar but differ from that of brain. 
SEVERAL laboratories have reported the identification of glycosaminoglycans (GAGs) 
in different nervous tissues. ABOOD and ABUL-HAJ (1956) showed histochemically 
the presence of hyaluronic acid in peripheral nerve of bullfrogs. The work of SZABO 
and ROBOZ-EINSTEIN (1962) indicated the occurrence of sulphated and non-sulphated 
GAG in bovine spinal cord and brain. Further they noticed that the concentration 
of sulphated GAG in spinal cord was much less than in brain. This finding prompted 
us to extend our investigation on the nature of GAG in brain to spinal cord as well 
as to peripheral nerve. The present paper reports on the isolation and characterization 
of uronic acid-containing GAGs in spinal cord and peripheral nerve of monkey. 
MATERIALS A N D  METHODS 
Cetyl pyridinium bromide was obtained from Mann Research Laboratories, U.S.A. and chondroi- 
tin-6-sulphate from Miles Research Laboratories. Glucosamine-IiCI, galactosamine-HCI, hyaluronic 
acid and testicular hyaluronidase type I were supplied by Sigma Chemicals, U.S.A. Sephadex G-75 
and DEAE-Sephadex A-25 were obtained from Pharmacia Uppsala, Sweden. Papain (crude) and 
pronase B were received respectively from Central Food Technological Research Institute, Mysore, 
and California Biochemical Corporation, U.S.A. Other reagents used were of analytical grade. 
The processing of the tissues for the isolation of GAGs was carried out as described earlier 
(SINGH and BACHHAWAT, 1968), and 12.2 g of lipid free dry tissue were obtained from 77.3 g spinal 
cord and 11.1 g from 52.7 g peripheral nerves (median and lateral popliteal). 
Amdyes.  The modification of the carbazole reaction (DISCHE, 1947) by BITTER and MUIR (1962) 
was used to estimate uronic acid. Dermatan sulphate was identified by making use of its very low 
colour yield in carbazole reaction without borate. The total hexosamine, galactosamine, sulphate, 
non-acetylated hexosamine (N-sulphate), chondroitin-6-sulphate and hyaluronidase resistant GAG 
were estimated as described earlier (CHANDRASEKARAN and BACHHAWAT, 1969). 
RESULTS 
Table 1 presents the concentration of the three GAG fractions isolated from the 
tissues by the cetyl pyridinium procedure. Peripheral nerve contains twice the amount 
of GAG present in spinal cord. In both tissues the ratios of fractions I to IT are 
Abbreviation used: GAG, glycosaminoglycans. 
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TABLE 1 .-CONCENTRATION OF GAG-FRACTIONS IN NERVOUS TISSUES 
f ig  uronic acid/g dry defatted tissue 
Tissue Fraction I Fraction 11 Fraction 111 Total Ratio 1/11 
.- . 
Spinal cord 486 209 14 709 2.33 
Peripheral nerve 1010 41 5 31 1456 2.44 
Brain* 1550 1320 2 2872 1.18 
* For comparison, the values taken from an earlier paper (SINGH et al., 1969). 
roughly the same and fraction I11 is very low. Further resolution of fractions I 
and I1 by DEAE-Sephadex chromatography (Table 2) shows the fraction I-SB is 
very low in peripheral nerve and fraction 11-SB constitutes 28-33 per cent of fraction 
11-SC in both tissues. The results of the analyses of fractions are given in Table 3. 
Fraction I-SA. In both tissues this fraction consists of glucosamine only and very 
little non-acetylated amino sugar. It is completely digestible by hyaluronidase 
indicating the glycosaminoglycan in this fraction is hyaluronic acid. 
Fruction I-SB. Amino sugar analyses indicate that this fraction in both tissues 
consists of 70 per cent glucosamine and 30 per cent galactosamine. The molar 
ratio of non-acetylated amino sugar to uronic acid is 0.36 in this fraction from both 
tissues showing that all the glucosamine-containing GAG can be accounted for as 
heparan sulphate. The presence of 0.59 molar sulphate with respect to uronic acid 
in this fraction from peripheral nerve indicates that the galactosamine-GAG is 
TABLE 2.-THE LEVELS OF DEAE-SEPHADEX FRACTIONS IN NERVOUS TISSUES 
I-SA 11-SB 
I-SB 11-sc 
p g  uronic acid/g dry defatted tissue 
~ 
Tissue I-SA I-SB I[-SB 11-sc 
Spinal cord 447 39 52 157 11.5 0.33 
Peripheral nerve 970 40 91 324 24.3 0.28 
Brain* 1368 182 528 792 7.5 0.66 
* The values reported from an earlier paper for comparison (SINGH et al., 1969). 
TABLE 3.-ANALYTICAL DATA OF T H E  DEAE-SEPHADEX FRACTIONS ISOLATED FROM SPINAL CORD 
AND PERIPHERAL NERVE 
As percentage of total GAG 
in the fraction Expressed as molar ratio of uronic acid 
Tissue and Hexos- Galactosamine Non-acetylated Chondroitin- Hyaluronidase 
fraction amine Glucosarnine hexosamine Sulphate 6-sulphate resistant 
Spinal cord : 
I-SA 0.75 Glucosamine 0.04 0.12 - Nil 
I-SB 0.75 0.43 0.36 N.D. 31 * N.D. 
11-SB 0.70 1 .oo 0.27 0.49 25 * N.D. 
11-sc 0.90 Galactosamine 0.02 0.93 20 8 
Peripheral 
nerve : 
I-SA 0.80 Glucosamine 0.04 0.10 - Nil 
I-SB 0.70 0.40 0.36 0.59 30 * N.D. 
11-SB 0.80 0.80 0.28 0.51 14' N.D. 
11-sc 0.80 Galactosamine 0.03 0.90 12 23 
* Would include low-sulphated chondroitin-4-sulphate (SINGH and BACHHAWAT, 1968). 
N.D.-Not done because of insufficient material. 
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low-sulphated. The chondroitin-6-sulphate value obtained from hyaluronidase- 
digestion method would include low-sulphated chondroitin-4-sulphate also (SINGH 
and BACHHAWAT, 1968). It is 30 per cent of the fraction in both tissues. 
Fraction ZZ-SB. In spinal cord this fraction consists of 50 per cent each of glucosa- 
mine and galactosamine and in peripheral nerve glucosamine is 56 per cent of the 
total hexosamine and the rest is galactosamine. The molar ratio of non-acetylated 
hexosamine to uronic acid is 0.27 in spinal cord and 0.28 in peripheral nerve, indicating 
that the glucosamine-GAG is heparan sulphate. The molar ratio of sulphate to 
uronic acid is 0.49 to 0.51 in this fraction from both tissues indicating that the galacto- 
samine-GAG is low-sulphated. Chondroitin-6-sulphate as estimated by hyaluroni- 
dase-digestion method was found to be 25 per cent of the fraction in spinal cord and 
14 per cent in peripheral nerve. These values would include low-sulphated chon- 
droitin-4-sulphate that may be present in this fraction. 
Fraction II-SC. The presence of galactosamine only as the amino sugar and very 
little non-acetylated amino sugar indicates the absence of heparan sulphate in this 
fraction. Sulphate is present in approximately equimolar ratio to uronic acid. 
The hyaluronidase-resistant GAG as estimated by Sephadex G-75 filtration of the 
hyaluronidase-digest comprises 8 per cent of the fraction in spinal cord and 23 per 
cent in peripheral nerve. The resistant GAG from peripheral nerve gave 41 per cent 
colour only in the carbazole reaction without borate indicating its nature to be derma- 
tan sulphate. Chondroitin-6-sulphate as estimated by hyaluronidase-digestion was 
found to be 25 per cent of this fraction in spinal cord and 12 per cent in peripheral 
nerve. 
The quantities of the identified GAGS in the various fractions are presented in 
Table 4. The major GAG is hyaluronic acid (63 per cent of the total GAG) and 
chondroitin-Csulphate is 16 per cent in both tissues. In spinal cord, heparan sulphate 
is 5-5 per cent and chondroitin-6-sulphate is 7.9 per cent; in peripheral nerve they are 
7.5 per cent and 5.2 per cent respectively. The chondroitin-6-sulphate value includes 
TABLE 4.-THE NATURE AND QUANTITY OF THE GLYCOSAMINOGLYCANS IN THE PERIPHERAL NERVE, 
SPINAL CORD AND BRAIN OF MONKEY 
pg uronic acid/g lipid free dry tissue 
GAG-Fractions Peripheral nerve Spinal cord Brain* 
I-SA : 
Hyaluronic acid 
Heparan sulphate 
Chondroitin-6-sulphate including low- 
sulphated chondroitin-4-sulphate 
Heparan suIphate 
Chondroitin-6-sulphate including low- 
sulphated chondroitin-4-sulphate 
Chondroitin-4-sulphate 
Hyaluronidase-resistant, 
Galactosamine-GAG 
Chondroitin-6-sulphate 
Chondroitin-4-sulphate 
I-SB : 
11-SB : 
11-sc: 
970 
28 
12 
52 
13 
26 
75 
39 
210 
447 1176 
27 73 
12 42 
26 253 
13 95 
13 180 
13 292 
31 136 
113 3 64 
* Values given from an earlier paper (SINGH et ~ l . ,  1969). 
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low-sulphated chondroitin-4-sulphate. The hyaluronidase resistant galactosamine- 
GAG is 3 per cent in spinal cord and 8 per cent in peripheral nerve. 
DISCUSSION 
The present study and our earlier investigations (SINGH and BACHHAWAT, 1968; 
SINGH, CHANDRASEKARAN, CHERIAN and BACHHAWAT, 1969) on the nature of GAG 
in brain indicate that all types of GAG are present in central and peripheral nervous 
systems. The present finding that the concentrations of total GAG in spinal cord 
and peripheral nerve are 25 per cent and 50 per cent respectively of the concentration 
of GAG in brain indicates the variation in the concentration of GAG in different 
parts of the central nervous system (brain and spinal cord) as well as in the two nervous 
systems (central and peripheral). This is further supported by the finding of SINGH 
(1967) that the concentration of GAG in human spinal cord is much less than in 
frontal grey and frontal white matter of human brain. 
Our work on the nature of GAG in brain of different species (SINGH et al,, 1969) 
showed that the patterns of GAGs in various brains are the same except in chicken 
brain. In the present study, it is noticed that the levels of various GAGs in spinal 
cord and peripheral nerve differ from that in brain. Hyaluronic acid comprises 
63 per cent of the total GAG in spinal cord and peripheral nerve whereas it is 41 per 
cent only in brain. Though hyaluronic acid is the major GAG and chondroitin-4- 
sulphate is the next prominent GAG in all nervous tissues, the levels of heparan 
sulphate and chondroitin-6-sulphate are lower in spinal cord and peripheral nerve, 
when compared to brain. Further, the hyaluronidase-resistant galactosamine-GAG 
is less in peripheral nerve and is in trace amount in spinal cord. The hyaluronidase- 
resistant GAG in peripheral nerve was found to be dermatan sulphate. 
SZABO and ROBOZ-EINSTEIN (1962) reported the ratio of hyaluronic acid to chon- 
droitin sulphate as 3 in bovine spinal cord and 0.8 in bovine brain. Comparable 
with these values, we find the ratio of hyaluronic acid to sulphated galactosamine- 
GAG in spinal cord and peripheral nerve as 2.5 whereas the ratio is 1-1 in monkey 
brain. 
ABOOD and ABUL-HAJ (1956) have identified hyaluronic acid histochemically in 
a comparatively high concentration in the axoplasm and between the myelin and 
neurilemma sheath of the peripheral nerves from bullfrogs. In myelin sheath of rat 
peripheral nerve, WOLMAN (1957) found a weakly acidic polysaccharide. Consistent 
with these findings, the present study indicates that hyaluronic acid is the most 
predominant GAG in peripheral nerve. 
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